Related Experiment Video
Updated: May 22, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Dual-Hyperbranched Strategy Enabling Remarkable Selectivity and Broad-Spectrum Antibacterial and Anticancer
Shuting Huang1, Chenyun Shen2, Yusheng Qian1
1School of Material Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China.
None:
Microbes, including both Gram-positive and Gram-negative bacteria, contribute to tumor initiation, progression, and metastasis. This complex association requires agents for a concurrent broad-spectrum antibacterial and anticancer therapy. Herein, we report a novel dual-hyperbranched strategy that constructs host-defense peptide mimics with a hydrophobic aliphatic acid interlayer and an outer hydrophilic polylysine shell to address this challenge. This unique structure resulted in a shared membranolytic mechanism targeting membranes with excessive negative charges, achieving potent activity against various bacteria and cancer cells. More importantly, the dual-hyperbranched strategy reduces toxicity significantly, which was attributed to the restriction of the mobility of hydrophobic segments. In vivo experiments further confirmed these concurrent activities and safety to normal tissues. Collectively, this work provides a new strategy for the design of cationic HDP-mimetic polymers and highlights their potential for integrated antibacterial and anticancer therapy.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inhibitors of Bacterial DNA Synthesis
Treatment Resistant Cancers
Antibiotic Selection
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
